Studies Toward a Genetic Understanding of Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2001 - March 31, 2003
Grant ID
G2001023
Summary
Differing environmental factors combined with the many genetic variations between those who have glaucoma and those who do not make it difficult to identify the specific genes responsible for glaucoma in humans. Many of the difficulties of studying glaucoma in humans can be alleviated by using mice because the two species share many crucial genes. Dr. John has been developing a mouse model to help scientists determine the genetics of glaucoma. One aim of the current study is to identify genes that contribute to the malformation of the iris and ocular drainage structures in NM1839 mice, because the eyes of these mice are malformed in a similar fashion to some human eyes that develop glaucoma. The other goal is to extend the results of a previous project, and this will involve an analysis of genetic factors that modify the severity of glaucomatous damage associated with high IOP. Dr. John has previously shown that the introduction of some genes from a non-glaucomatous mouse strain (B6) alleviates the glaucoma phenotype in a glaucomatous mouse strain (D2). He is now extending his initial studies to definitively characterize the glaucoma susceptibilities of D2 and B6 mice. It is hoped that the completion of this aim will provide important information to help identify genes that alter glaucoma susceptibility in humans. This study is a continuation of a former BrightFocus-funded study of the same name, commenced in 1997.
Grantee institution at the time of this grant: The Jackson Laboratory
Related Grants
National Glaucoma Research
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
Exploring Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Qi Cui, MD, PhD
Current Organization
University of Pennsylvania, Perelman School of Medicine
National Glaucoma Research
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
Measuring the Effects of Visual Stimuli on Retinal Blood Vessels and Flow
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Stuart Gardiner, PhD
Current Organization
Good Samaritan Foundation, Legacy Health System
National Glaucoma Research
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine
Reducing Inflammation to Protect Vision in Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Cátia Gomes, PhD
Current Organization
Indiana University School of Medicine